Beyond HumanBig PictureCatalystsConnected WorldExchangeMarketing MixNew MoneyNew SchoolPeople SciencePulse

How should pharmaceuticals harness the power of AI to transform clinical trials?

Roy Smythe

Roy Smythe explains how AI can bring about much needed change in the clinical trials system by addressing the shortage of human volunteers.

“Big data and AI have the potential to make clinical trials more effective, efficient and equitable,” according to Roy Smythe, Chief Medical Officer, Strategy and Partnerships for Philips, at the time of filming.

Therapeutics companies are struggling to recruit enough participants for clinical trials, but by using AI to create digital twins to plug this shortfall, potentially life-saving drugs can be put on the market quicker.

This interview is part of The Age of Transformation: How can Pharma Harness the Power of Data? A series powered by Medidata.